A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS (NCT07551999) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS
United States40 participantsStarted 2026-05
Plain-language summary
The purpose of this research is to evaluate the use of a voice-based tool in the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) verified by an ME/CFS specialist.
* Ability to complete study questionnaires and provide voice samples using a smartphone application.
* Consistent access to a smartphone or tablet with iOS or Android operating systems, or a laptop.
Exclusion Criteria:
* No diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); "Chronic Fatigue Syndrome" not verified by an ME/CFS specialist.
* Lack of consistent access to a smartphone or tablet with iOS or Android operating systems, or laptop.
* Known dementia or other neurodegenerative disorder prominently affecting cognition or speech patterns. outside of ME/CFS
* Known history of voice disorder either primary or secondary to neuromuscular or other pathology outside of ME/CFS
* Known clinically significant heart failure or greater than moderate pulmonary hypertension.
What they're measuring
1
Feasibility of Mayo Speech Test (Voice Signatures) for Screening of ME/CFS
Timeframe: 12 weeks
2
Feasibility of Mayo Speech Test (Voice Signatures) for Monitoring of ME/CFS